Skip to main content

Advertisement

SpringerLink
Log in

Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Recent studies have demonstrated the efficacy of PUVA (psoralen plus ultraviolet A irradiation) therapy against sclerotic skin lesions in scleroderma, although the mechanisms underlying the improvement of the skin sclerosis by this therapy remain unknown. We investigated the effects of ultraviolet A (UVA) irradiation following the treatment with 8-methoxypsoralen on types I and III collagen synthesis and the gene expression of collagenase in cultured normal and scleroderma fibroblasts. The treatment reduced types I and III collagen synthesis and consequently, the types I and III collagen mRNA levels, in a UVA dose-dependent manner in both the normal and SSc fibroblasts, whereas the mRNA levels of collagenase remained almost unaltered. These results suggest that reduction of collagen synthesis by the fibroblasts may be one of the mechanisms underlying the efficacy of PUVA therapy against the sclerotic skin lesions in scleroderma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Angel P, Pöting A, Mallick U, Rahmsdorf HJ, Schorpp M, Herrlich P (1986) Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 6:1760–1766

    PubMed  CAS  Google Scholar 

  2. Arcari P, Martinelli R, Salvatore F (1984) The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucl Acids Res 12:9179–9189. doi:10.1093/nar/12.23.9179

    Article  PubMed  CAS  Google Scholar 

  3. Besaratinia A, Pfeifer GP (2004) Biological consequences of 8-methxypsoralen-photoinduced lesions: sequence-specificity of mutations and preponderance of T to C and T to A mutations. J Invest Dermatol 123:1140–1146. doi:10.1111/j.0022-202X.2004.23502.x

    Article  PubMed  CAS  Google Scholar 

  4. Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X (1999) Interferon-α does not improve outcome at One year in patients with diffuse cutaneous scleroderma:results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 42:299–305. doi:10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R

    Article  PubMed  CAS  Google Scholar 

  5. Chu ML, Myers JC, Bernard MP, Ding JF, Ramirez F (1982) Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res 10:5925–5934. doi:10.1093/nar/10.19.5925

    Article  PubMed  CAS  Google Scholar 

  6. Chu M-L, Mann K, Deutzmann R, Pribula Conway D, Hsu-Chen CC, Bernard MP, Timpl R (1987) Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones. Eur J Biochem 168:309–317. doi:10.1111/j.1432-1033.1987.tb13422.x

    Article  PubMed  CAS  Google Scholar 

  7. Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK (1999) High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis:anaiysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 42:1194–1203. doi:10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7

    Article  PubMed  CAS  Google Scholar 

  8. Denton CP, Merkel A, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, Streisand J, Powell J, Akesson A, Coppock J, Hoogen F, Herrick A, Mayes MD, Veale D, Haas J, Ledbetter S, Korn JH, Black CM, Seibold JR, Cat-192 Study Group; Scleroderma Clinical Trials Consortium (2007) Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic scierosis: a multicenter, randomized, placebocontrolled phase I/II trial of CAT-192. Arthritis Rheum 56:323–333. doi:10.1002/art.22289

    Google Scholar 

  9. de Wet W, Bernard M, Benson-Chanda V, Chu ML, Dickson L, Weil D, Ramirez F (1987) Organization of the human pro-α2(I) collagen gene. J Biol Chem 262:16032–16036

    PubMed  Google Scholar 

  10. Fleischmajer R, Perlish JS, Krieg T, Timple R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403. doi:10.1111/1523-1747.ep12520933

    Article  PubMed  CAS  Google Scholar 

  11. Hashikabe M, Ohtsuka T, Yamazaki S (2005) Quantitative echographic analysis of photochemotheray on systemic sclerosis skin. Arch Dermatol Res 296:522–527. doi:10.1007/s00403-005-0552-1

    Article  PubMed  CAS  Google Scholar 

  12. Hatamochi A, Aumailley M, Mauch C, Chu M-L, Timpl R, Krieg T (1989) Regulation of collagen VI expression in fibroblasts Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem 264:3494–3499

    PubMed  CAS  Google Scholar 

  13. Heckmann M, Aumailley M, Hatamochi A, Chu M-L, Timpl R, Krieg T (1989) Down-regulation of alpha 3(VI) chain expression by gamma- interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem 182:719–726. doi:10.1111/j.1432-1033.1989.tb14884.x

    Article  PubMed  CAS  Google Scholar 

  14. Herrmann G, Brenneisen P, Wlaschek M, Wenk J, Faisst K, Quel G, Hommel C, Goerz H, Goerz G, Ruzicka T, Thomas R, Krieg T, Sies H, Scharffetter-Kochanek K (1998) Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci 111:759–767

    PubMed  CAS  Google Scholar 

  15. Jander R, Rauterberg J, Glanville RW (1983) Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen). Eur J Biochem 133:39–46. doi:10.1111/j.1432-1033.1983.tb07427.x

    Article  PubMed  CAS  Google Scholar 

  16. Jimenez SA, Hitraya E, Varga J (1996) Pathogenesis of scleroderma collagen. Rheum Dis Clin North Am 22:647–674. doi:10.1016/S0889-857X(05)70294-5

    Article  PubMed  CAS  Google Scholar 

  17. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Röchen M (1994) Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet 343:1233. doi:10.1016/S0140-6736(94)92449-X

  18. Kerscher M, Dirschka T, Volknandt M (1995) Treatment of localized scleroderma by PUVA phototheraoy. Lancet 346:1166. doi:10.1016/S0140-6736(95)91843-4

  19. Kanekura T, Fukumaru S, Matsushita S, Terasaki K, Mizoguchi S, Kanzaki T (1996) Successful treatmet of scleroderma with PUVA therapy. J Dermatol 23:455–459

    PubMed  CAS  Google Scholar 

  20. Liau G, Yamada Y, de Crombrugghe B (1985) Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem 260:531–536

    PubMed  CAS  Google Scholar 

  21. Lichtenstein JR, Byers PH, Smith BD, Martin GR (1975) Identification of the collagenous proteins synthesized by cultured cells from human skin. Biochemistry 22:1589–1594. doi:10.1021/bi00679a007

    Article  Google Scholar 

  22. Miskulin M, Dalgleish R, Kluve-Beckerman B, Rennard SI, Tolstoshev P, Brantly M, Crystal RG (1986) Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry 25:1408–1413. doi:10.1021/bi00354a033

    Article  PubMed  CAS  Google Scholar 

  23. Mori K, Hatamochi A, Ueki H, Olsen A, Jimenez SA (1996) The transcription of humanα1(I)procollagen gene(COL 1 A 1) is suppressed by tumor necrosis factor-αthrough proximal short promoter elements-evidence for suppression mechanisms mediated by two nuclear factor binding sites. Biochem J 319:811–816

    PubMed  CAS  Google Scholar 

  24. Morita A, Sakakibara S, Skakibara N, Yamauchi R, Tsuji T (1995) Successful treatment of systemic sclerosis with topical PUVA. J Rheumatol 22:2361–2365

    PubMed  CAS  Google Scholar 

  25. Olsen D, Peltonen J, Jaakkola S, Chu M-L, Uitto J (1989) Collagen gene expression by human skin fibroblasts: abundant steady-state levels of type VI procollagen mRNAs. J Clin Invest 183:791–795. doi:10.1172/JCI113959

    Article  Google Scholar 

  26. Parker ML, Judge K, Gevers W (1982) Loss of type I procollagen gene expression in SV40-transformed human fibroblasts is accompanied by hypermethylation of these genes. Nucleic Acids Res 10:5879–5891. doi:10.1093/nar/10.19.5879

    Article  PubMed  CAS  Google Scholar 

  27. Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS (1996) A multicenter trial of recombinant human interferon γ in patients with systemi sclerosis:effects on cutaneous fibrosis and interleukin 2 receptor levels. J Rheumatol 23:654–658

    PubMed  CAS  Google Scholar 

  28. Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA (2000) CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum 43:2219–2229. doi:10.1002/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO;2-N

    Article  PubMed  CAS  Google Scholar 

  29. Sato M, Shegogue D, Hatamochi A, Yamazaki S, Trojanowska M (2004) Lysophosphatidic acid inhibits TGF-beta-mediated stimulation of type I collagen mRNA stability via an ERK-dependent pathway in dermal fibroblasts. Matrix Biol 23:353–361. doi:10.1016/j.matbio.2004.07.005

    Article  PubMed  CAS  Google Scholar 

  30. Scharffetter K, Wlaschek M, Hoog A, Bolsen K, Schothorst A, Goerz G, Krieg T, Plewig G (1991) UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 283:506–511. doi:10.1007/BF00371923

    Article  PubMed  CAS  Google Scholar 

  31. Scharffetter-Kochanek K, Goldermann R, Lehmann P, Hölzle E, Goerz G (1995) PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol 132(5):830–831

    Article  PubMed  CAS  Google Scholar 

  32. Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannign J, Harkonen WS, Sanders ME (2000) Recombinant human relaxin in the treatment of scleroderma: a randomized, double, placebo-controlled trial. Ann Intern Med 132:871–879

    PubMed  CAS  Google Scholar 

  33. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for theclassification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590. doi:10.1002/art.1780230510

    Article  Google Scholar 

  34. Trueb B, Winterhalter K (1986) Type IV collagen is composed of a 200 kd subunit and two 140 kd subunit. EMBO J 5:2815–2819

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan

    Yohei Kitamura, Hiromi Namikawa, Shujiro Hayashi, Takahiro Yoshida, Toshihiro Suzuki, Yoichiro Hamasaki, Soji Yamazaki & Atsushi Hatamochi

Authors
  1. Yohei Kitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiromi Namikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shujiro Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takahiro Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshihiro Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoichiro Hamasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Soji Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Atsushi Hatamochi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsushi Hatamochi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitamura, Y., Namikawa, H., Hayashi, S. et al. Effects of UVA irradiation following treatment with 8-methoxypsoralen on type I and type III collagen synthesis in normal and scleroderma fibroblast cultures. Arch Dermatol Res 301, 507–513 (2009). https://doi.org/10.1007/s00403-009-0949-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0949-3

Keywords

Search

Navigation